Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by ...

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...

Inside the Booming mRNA Therapeutics MarketThe mRNA Cancer Vaccines and Therapeutics Market has emerged as one of the most transformative frontiers in oncology and biotechnology. These advanced ...

The study is testing INBRX-106, a hexavalent OX40 agonist antibody, designed to enhance the immune response against tumors. It is administered alone or with pembrolizumab, a well-known anti-PD-1 ...

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

A review of cardioprotective strategies for cancer therapy suggests risk stratification prior to initiating potentially cardiotoxic therapy.

Data from an exploratory analysis of the pivotal phase 3 MIRASOL trial (NCT04209855) were recently unveiled at the 2025 European Society for Medical Oncology (ESMO) Congress, opening a broader ...

Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.

The technique, known as IORT, has numerous benefits, surgeons say, but it generates less money for hospitals and radiation ...

Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...